Doxorubicin conjugated NaYF4: Yb3+/Tm3+ Nanoparticles for therapy and sensing of drug delivery by luminescence resonance energy transfer

Biomaterials

Volumn 33, Issue 33, 2012, Pages 8704-8713

  Dai, Yunlu ^a,b   Yang, Dongmei ^a,b   Ma, Ping'an ^a   Kang, Xiaojiao ^a,b   Zhang, Xiao ^a   Li, Chunxia ^a   Hou, Zhiyao ^a   Cheng, Ziyong ^a   Lin, Jun ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Doxorubicin; Luminescence resonance energy transfer; PH responsive drug release; Up conversion nanopatricles

Indexed keywords

ABSORBANCES; ACIDIC ENVIRONMENT; ANTI-CANCER DRUG DELIVERY; AVERAGE DIAMETER; CANCER THERAPY; CONFOCAL LASER SCANNING MICROSCOPY; CYTOTOXIC EFFECTS; DOXORUBICIN; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDRAZONE BONDS; ICP-OES; MTT ASSAYS; OPTICAL PROBE; OVARIAN CANCER CELLS; POTENTIAL APPLICATIONS; RESONANCE ENERGY TRANSFER; SMART IMAGING; SPHERICAL NANOPARTICLES; UP-CONVERSION; UP-CONVERSION LUMINESCENCE;

CONFOCAL MICROSCOPY; CYTOTOXICITY; DRUG DELIVERY; ENERGY TRANSFER; FLOW CYTOMETRY; LUMINESCENCE; NANOPARTICLES; RESONANCE; YTTERBIUM;

SYNTHESIS (CHEMICAL);

DOXORUBICIN; HYDRAZONE DERIVATIVE; NANOPARTICLE;

ARTICLE; CANCER CELL; CELL TRANSPORT; CHEMICAL BOND; CONFOCAL LASER MICROSCOPY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DONOR; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENERGY TRANSFER; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LUMINESCENCE; LUMINESCENCE RESONANCE ENERGY TRANSFER; MOLECULAR PROBE; OVARY CANCER; PH; PRIORITY JOURNAL; SYNTHESIS;

CELL LINE, TUMOR; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; LUMINESCENCE; MICROSCOPY, CONFOCAL; NANOPARTICLES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84866154378     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.08.029     Document Type: Article

References (57)

1. Yang P.P., Gai S.L., Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012, 41:3679-3698.
2. Li Z.X., Barnes J.C., Bosoy A., Stoddart J.F., Zink J.I. Mesoporous silica nanoparticles in biomedical applications. Chem Soc Rev 2012, 41:2590-2605.
3. Xue X.J., Wang F., Liu X.G. Emerging functional nanomaterials for therapeutics. J Mater Chem 2011, 21:13107-13127.
4. Kievit F.M., Zhang M. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater 2011, 23:H217-H247.
5. Singh B., Kapil R., Nandi M., Ahuja N. Developing oral drug delivery systems using formulation by design: vital precepts, retrospect and prospects. Expert Opin Drug Deliv 2011, 8:1341-1360.
6. Chen K.-J., Chiu Y.-L., Chen Y.-M., Ho Y.-C., Sung H.-W. Intracellularly monitoring/imaging the release of doxorubicin from pH-responsive nanoparticles using Förster resonance energy transfer. Biomaterials 2011, 32:2586-2592.
7. Stark W.J. Nanoparticles in biological systems. Angew Chem Int Ed 2011, 50:1242-1258.
8. Wang C., Tao H., Cheng L., Liu Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32:6145-6154.
9. Prabaharan M., Grailer J.J., Pilla S., Steeber D.A., Gong S. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery. Biomaterials 2009, 30:6065-6075.
10. Wang F., Wang Y.-C., Dou S., Xiong M.-H., Sun T.-M., Wang J. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cells. ACS Nano 2011, 5:3679-3692.
11. Lim E.-K., Huh Y.-M., Yang J., Lee K., Suh J.-S., Haam S. pH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI. Adv Mater 2011, 23:2436-2442.
12. Brannon-Peppas L., Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004, 56:1649-1659.
13. Gao X., Cui Y., Levenson R.M., Chung L.W.K., Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
14. Gibson J.D., Khanal B.P., Zubarev E.R. Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 2007, 129:11653-11661.
15. Savla R., Taratula O., Garbuzenko O., Minko T. Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J Control Release 2011, 153:16-22.
16. 4 nanoparticle cores and a PEG-functionalized porous silica shell. Chem Commun 2010, 46:8633-8635.
17. 4 nanocrystals as potential optical/magnetic multimodal bioprobes. J Am Chem Soc 2012, 134:1323-1330.
18. 4 nanocrystals. Adv Mater 2010, 22:3266-3271.
19. Haldar K.K., Sen T., Patra A. Metal conjugated semiconductor hybrid nanoparticle-based fluorescence resonance energy transfer. J Phys Chem C 2010, 114:4869-4874.
20. Ju Q., Tu D.T., Liu Y.S., Zhu H.M., Chen X.Y. Lanthanide-doped inorganic nanocrystals as luminescent biolabels. Comb Chem High T Scr 2012, 15:580-594.
21. Andrey L.R. Fluorescence energy transfer in hybrid structures of semiconductor nanocrystals. Nano Today 2011, 6:355-365.
22. 4 nanocrystals. Angew Chem Int Ed 2011, 50:6306-6310.
23. Cheng L., Yang K., Shao M., Lee S.-T., Liu Z. Multicolor in vivo imaging of upconversion nanoparticles with emissions tuned by luminescence resonance energy transfer. J Phys Chem C 2011, 115:2686-2692.
24. Gumbleton M., Stephens D.J. Coming out of the dark: the evolving role of fluorescence imaging in drug delivery research. Adv Drug Deliv Rev 2005, 57:5-15.
25. Sharma A.K., Son K.H., Han B.Y., Sohn K.-S. Simultaneous optimization of luminance and color chromaticity of phosphors using a nondominated sorting genetic algorithm. Adv Funct Mater 2010, 20:1750-1755.
26. 3 nanocrystals for time-resolved photoluminescent biodetection. Chem Eur J 2011, 17:8549-8554.
27. 3+@hydrogel core-shell hybrid microspheres. ACS Nano 2012, 6:3327-3338.
28. Wang Z.L., Hao J.H., Chan L.W., Law G.L., Wong W.T., Wong K.L., et al. Simultaneous synthesis and functionalization of water-soluble up-conversion nanoparticles for in-vitro cell and nude mouse imaging. Nanoscale 2011, 3:2175-2181.
29. 2 nanocrystals: crystal-field levels, excited-state dynamics, upconversion and defect luminescence. Small 2011, 7:3046-3056.
30. Mai H.-X., Zhang Y.-W., Si R., Yan Z.G., Sun L.D., You L.P., et al. High-quality sodium rare-earth fluoride nanocrystals: controlled synthesis and optical properties. J Am Chem Soc 2006, 128:6426-6436.
31. 4 nanocrystal core/shell structure. J Am Chem Soc 2009, 131:14644-14645.
32. 3+ doped fluoride nanophosphors. Nano Lett 2008, 8:3834-3838.
33. Haase M., Schäfer H. Upconverting nanoparticles. Angew Chem Int Ed 2011, 50:5808-5829.
34. 4 nanocrystals. Chem Eur J 2009, 15:9660-9663.
35. 2-nanosheet-modified upconversion nanoparticles. J Am Chem Soc 2011, 133:20168-20171.
36. Liu J., Liu Y., Liu Q., Li C., Sun L., Li F. Iridium(III) complex-coated nanosystem for ratiometric upconversion luminescence bioimaging of cyanide anions. J Am Chem Soc 2011, 133:15276-15279.
37. 4 nanocrystals. Nanoscale 2012, 4:4485-4491.
38. Yang Y., Shao Q., Deng R., Wang C., Teng X., Cheng K., et al. In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angew Chem Int Ed 2012, 51:3125-3129.
39. 3+-poly(acrylic acid) hybrid microspheres. Biomaterials 2012, 33:2583-2592.
40. Chen L., Chu C.-I., Chen K.-J., Chen P.-Y., Hu S.-F., Liu R.-S. An intelligent approach to the discovery of luminescent materials using a combinatorial approach combined with taguchi methodology. Luminescence 2011, 26:229-238.
41. Ju Q., Luo W.Q., Liu Y.S., Zhu H.M., Li R.F., Chen X.Y. Poly (acrylic acid)-capped lanthanide-doped BaFCl nanocrystals: synthesis and optical properties. Nanoscale 2010, 2:1208-1212.
42. Luo S., Zhang E., Su Y., Cheng T., Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials 2011, 32:7127-7138.
43. Guo H., Idris N.M., Zhang Y. LRET-based biodetection of DNA release in live cells using surface-modified upconverting fluorescent nanoparticles. Langmuir 2011, 27:2854-2860.
44. Vetrone F., Naccache R., Morgan C.G., Capobianco J.A. Luminescence resonance energy transfer from an upconverting nanoparticle to a fluorescent phycobiliprotein. Nanoscale 2010, 2:1185-1189.
45. Li C.X., Lin J. Rare earth fluoride nano-/microcrystals: synthesis, surface modification and application. J Mater Chem 2010, 20:6831-6847.
46. Park J., An K., Hwang Y., Park J.G., Noh H.J., Kim J.Y., et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3:891-895.
47. 4: Yb, Er nanoplates. Chem Mater 2006, 18:5733-5737.
48. Chen Z., Chen H., Hu H., Yu M., Li F., Zhang Q., et al. Versatile synthesis strategy for carboxylic acid-functionalized upconverting nanophosphors as biological labels. J Am Chem Soc 2008, 130:3023-3029.
49. Banerjee S.S., Chen D.-H. Multifunctional pH-sensitive magnetic nanoparticles for simultaneous imaging, sensing and targeted intracellular anticancer drug delivery. Nanotechnology 2008, 19:505104.
50. Lee C.-H., Cheng S.-H., Huang I.P., Souris J.S., Yang C.S., Mou C.Y., et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem Int Ed 2010, 49:8214-8219.
51. Chen J., Qiu X., Ouyang J., Kong J., Zhong W., Xing M.M.Q. pH and reduction dual-sensitive copolymeric micelles for intracellular doxorubicin delivery. Biomacromolecules 2011, 12:3601-3611.
52. Moore M.N. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?. Environ Int 2006, 32:967-976.
53. Mellman I., Fuchs R., Helenius A. Acidification of the endocytic and exocytic pathways. Annu Rev Biochem 1986, 55:663-700.
54. Stubbs M., McSheehy P.M.J., Griffiths J.R., Bashford C.L. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000, 6:15-19.
55. Tangpong J., Miriyala S., Noel T., Sinthupibulyakit C., Jungsuwadee P., St.Clair D.K. Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia Mangostana. Neuroscience 2011, 175:292-299.
56. Dignam J.D., Qu X., Ren J., Chaires J.B. Daunomycin binding to detergent micelles: a model system for evaluating the hydrophobic contribution to drug-DNA interactions. J Phys Chem B 2007, 111:11576-11584.
57. Husain N., Agbaria R.A., Warner I.M. Spectroscopic analysis of the binding of doxorubicin to human.alpha.-1 acid glycoprotein. J Phys Chem 1993, 97:10857-10861.